genOway Société anonyme (EPA:ALGEN)

France · Delayed Price · Currency is EUR

2.440

+0.020 (0.83%)

Feb 27, 2026, 4:22 PM CET

-30.48% (1Y)

Market Cap	22.50M
Revenue (ttm)	27.16M
Net Income (ttm)	1.29M
Shares Out	9.22M
EPS (ttm)	n/a
PE Ratio	17.48
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2,015
Average Volume	6,055
Open	2.440
Previous Close	2.420
Day's Range	2.400 - 2.440
52-Week Range	2.100 - 3.550
Beta	0.51
RSI	47.50
Earnings Date	Mar 27, 2026

About genOway Société anonyme

genOway Société anonyme, a biotechnology company, engages in the development and commercialization of custom genetically modified mouse, rat, and cell line models worldwide. It produces customized mouse models, such as knockout (KO) and knockin (KI) mouse models; customized rat models, including constitutive and conditional KO, point mutation KI, and quick KI rat models; and customized cell lines, such as constitutive and inducible KO, point mutation KI, reporter KI, quick KI, and KI cell lines. The company also offers humanized immune checkpoi... [Read more]

Industry Biotechnology

Sector Healthcare

Founded 1999

Employees 148

Stock Exchange Euronext Paris

Ticker Symbol ALGEN

Full Company Profile

Financial Performance

In 2024, genOway Société anonyme's revenue was 27.53 million, an increase of 3.85% compared to the previous year's 26.51 million. Earnings were 1.83 million, an increase of 16.79%.

Financial Statements

News

There is no news available yet.